 John Morton
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 10 | 2023 | 527 | 1.320 |
Why?
| | Immunotherapy | 2 | 2020 | 584 | 1.010 |
Why?
| | Xenograft Model Antitumor Assays | 9 | 2020 | 799 | 0.900 |
Why?
| | Bariatric Surgery | 3 | 2023 | 190 | 0.830 |
Why?
| | Disease Models, Animal | 6 | 2020 | 3999 | 0.760 |
Why?
| | Neoplastic Stem Cells | 6 | 2020 | 376 | 0.700 |
Why?
| | Caenorhabditis elegans | 4 | 2013 | 301 | 0.700 |
Why?
| | Tumor Microenvironment | 4 | 2020 | 596 | 0.680 |
Why?
| | Carcinoma, Squamous Cell | 7 | 2019 | 626 | 0.610 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 50 | 0.600 |
Why?
| | Gastric Bypass | 1 | 2019 | 106 | 0.580 |
Why?
| | Hematopoietic Stem Cells | 2 | 2018 | 378 | 0.580 |
Why?
| | RNA, Helminth | 3 | 2013 | 17 | 0.480 |
Why?
| | Laparoscopy | 1 | 2019 | 453 | 0.470 |
Why?
| | Transcription Initiation Site | 2 | 2013 | 43 | 0.460 |
Why?
| | Operon | 2 | 2011 | 62 | 0.450 |
Why?
| | Melanoma | 1 | 2020 | 738 | 0.430 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 576 | 0.410 |
Why?
| | Trans-Splicing | 2 | 2013 | 16 | 0.390 |
Why?
| | Thymus Gland | 2 | 2023 | 307 | 0.360 |
Why?
| | DNA, Recombinant | 1 | 2010 | 46 | 0.360 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 87 | 0.340 |
Why?
| | Mice | 16 | 2023 | 16583 | 0.330 |
Why?
| | Animals | 22 | 2023 | 34708 | 0.290 |
Why?
| | Transplantation, Heterologous | 2 | 2018 | 190 | 0.280 |
Why?
| | Neoplasms | 2 | 2020 | 2429 | 0.250 |
Why?
| | T-Lymphocytes | 3 | 2023 | 1913 | 0.230 |
Why?
| | Genes, Helminth | 3 | 2013 | 26 | 0.210 |
Why?
| | Immunophenotyping | 3 | 2019 | 311 | 0.210 |
Why?
| | Hyaluronan Receptors | 2 | 2020 | 93 | 0.200 |
Why?
| | Hedgehog Proteins | 2 | 2014 | 187 | 0.200 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 76 | 0.200 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 175 | 0.190 |
Why?
| | SOXB1 Transcription Factors | 2 | 2020 | 55 | 0.170 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2020 | 41 | 0.170 |
Why?
| | Radiotherapy Dosage | 2 | 2020 | 249 | 0.160 |
Why?
| | Neoplasm Transplantation | 2 | 2016 | 255 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2019 | 51 | 0.160 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 86 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 219 | 0.150 |
Why?
| | Humans | 22 | 2023 | 129078 | 0.150 |
Why?
| | Peptides, Cyclic | 1 | 2020 | 258 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2016 | 2702 | 0.150 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 32 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 750 | 0.140 |
Why?
| | Cell Differentiation | 4 | 2023 | 1858 | 0.140 |
Why?
| | Mice, Nude | 5 | 2018 | 680 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2018 | 165 | 0.140 |
Why?
| | Cell Communication | 1 | 2018 | 293 | 0.140 |
Why?
| | Veratrum Alkaloids | 2 | 2014 | 18 | 0.140 |
Why?
| | Telomere | 1 | 2019 | 231 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2020 | 241 | 0.130 |
Why?
| | Cell Proliferation | 4 | 2019 | 2344 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2018 | 2774 | 0.130 |
Why?
| | Cell Line, Tumor | 6 | 2020 | 3114 | 0.130 |
Why?
| | ErbB Receptors | 3 | 2016 | 602 | 0.130 |
Why?
| | Radiometry | 1 | 2015 | 48 | 0.130 |
Why?
| | Radiotherapy, Conformal | 1 | 2015 | 70 | 0.120 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 124 | 0.120 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 168 | 0.120 |
Why?
| | Stromal Cells | 1 | 2014 | 104 | 0.110 |
Why?
| | Mice, Inbred NOD | 3 | 2023 | 579 | 0.110 |
Why?
| | Radiation Tolerance | 1 | 2014 | 97 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 2 | 2014 | 642 | 0.110 |
Why?
| | Base Sequence | 3 | 2013 | 2157 | 0.100 |
Why?
| | Sulfones | 1 | 2013 | 107 | 0.100 |
Why?
| | Glycine | 1 | 2013 | 162 | 0.100 |
Why?
| | Exercise | 1 | 2023 | 1924 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1318 | 0.100 |
Why?
| | Transcriptome | 2 | 2016 | 875 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1174 | 0.090 |
Why?
| | Gene Components | 1 | 2011 | 5 | 0.090 |
Why?
| | Genome, Helminth | 1 | 2010 | 3 | 0.090 |
Why?
| | RNA, Spliced Leader | 1 | 2010 | 12 | 0.090 |
Why?
| | RNA Splice Sites | 1 | 2011 | 40 | 0.090 |
Why?
| | Biomarkers | 2 | 2019 | 3878 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 478 | 0.090 |
Why?
| | Stem Cells | 1 | 2014 | 573 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 361 | 0.080 |
Why?
| | Obesity | 2 | 2020 | 2847 | 0.080 |
Why?
| | RNA Splicing | 1 | 2010 | 254 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2013 | 570 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1697 | 0.080 |
Why?
| | Signal Transduction | 4 | 2016 | 4867 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 957 | 0.080 |
Why?
| | Models, Biological | 1 | 2015 | 1704 | 0.080 |
Why?
| | DNA Nucleotidyltransferases | 1 | 2008 | 11 | 0.080 |
Why?
| | Cytokines | 1 | 2016 | 1997 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2020 | 131 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 422 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2846 | 0.060 |
Why?
| | Epithelial Cells | 2 | 2023 | 1063 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 2018 | 929 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2021 | 4063 | 0.060 |
Why?
| | Papillomaviridae | 2 | 2016 | 112 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1572 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2020 | 576 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 380 | 0.050 |
Why?
| | Cetuximab | 2 | 2013 | 93 | 0.050 |
Why?
| | Antigens, CD | 2 | 2016 | 480 | 0.050 |
Why?
| | Physical Fitness | 1 | 2023 | 200 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 100 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 225 | 0.050 |
Why?
| | Life Style | 1 | 2023 | 459 | 0.050 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 24 | 0.040 |
Why?
| | Feedback, Physiological | 1 | 2020 | 75 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2023 | 406 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 129 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2020 | 207 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 214 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 208 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 395 | 0.040 |
Why?
| | DNA Damage | 1 | 2020 | 377 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 553 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3047 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 480 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 582 | 0.030 |
Why?
| | Retinal Dehydrogenase | 1 | 2016 | 33 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 201 | 0.030 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1195 | 0.030 |
Why?
| | Absorption, Radiation | 1 | 2015 | 3 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 70 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1286 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2016 | 103 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 724 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 186 | 0.030 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2014 | 23 | 0.030 |
Why?
| | Mutation | 2 | 2018 | 3679 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1013 | 0.030 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2014 | 14 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 34 | 0.030 |
Why?
| | Cell Division | 1 | 2016 | 802 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 322 | 0.030 |
Why?
| | Integrin alpha Chains | 1 | 2013 | 22 | 0.030 |
Why?
| | Cross-Priming | 1 | 2013 | 18 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 952 | 0.030 |
Why?
| | Receptors, Chemokine | 1 | 2013 | 46 | 0.030 |
Why?
| | CD11b Antigen | 1 | 2013 | 59 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2013 | 58 | 0.030 |
Why?
| | Mice, SCID | 1 | 2014 | 340 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 125 | 0.030 |
Why?
| | Receptor, Notch2 | 1 | 2013 | 15 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 229 | 0.030 |
Why?
| | Gonanes | 1 | 2013 | 27 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2014 | 267 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 81 | 0.030 |
Why?
| | Integrins | 1 | 2013 | 94 | 0.030 |
Why?
| | 5' Untranslated Regions | 1 | 2013 | 54 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2013 | 88 | 0.030 |
Why?
| | Th17 Cells | 1 | 2013 | 81 | 0.030 |
Why?
| | Alphapapillomavirus | 1 | 2013 | 40 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 190 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 62 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 308 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2013 | 228 | 0.030 |
Why?
| | Organ Specificity | 1 | 2013 | 296 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 181 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 479 | 0.020 |
Why?
| | Fetal Blood | 1 | 2014 | 315 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 350 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2250 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 627 | 0.020 |
Why?
| | Female | 4 | 2020 | 68274 | 0.020 |
Why?
| | Glycoproteins | 1 | 2013 | 340 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 772 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2523 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 850 | 0.020 |
Why?
| | Computer Simulation | 1 | 2015 | 943 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1696 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3290 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1842 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 377 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2607 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1189 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 778 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1147 | 0.020 |
Why?
| | Papillomavirus Infections | 1 | 2013 | 290 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 638 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2485 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 588 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2082 | 0.020 |
Why?
| | Tetanus Toxin | 1 | 2008 | 6 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 738 | 0.020 |
Why?
| | Algorithms | 1 | 2015 | 1626 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2008 | 70 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2008 | 232 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2008 | 186 | 0.020 |
Why?
| | Luminescent Proteins | 1 | 2008 | 180 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 522 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1636 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 392 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2008 | 361 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10256 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2043 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5282 | 0.010 |
Why?
| | Male | 2 | 2020 | 63248 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 14562 | 0.010 |
Why?
| | Aged | 1 | 2019 | 22068 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 31024 | 0.010 |
Why?
| | Adult | 1 | 2014 | 35423 | 0.010 |
Why?
|
|
Morton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|